Northwest Investment Counselors LLC purchased a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 8,986 shares of the company’s stock, valued at approximately $730,000.
Other large investors have also added to or reduced their stakes in the company. Gradient Investments LLC purchased a new position in GE HealthCare Technologies during the 2nd quarter valued at about $37,000. Peoples Financial Services CORP. bought a new position in shares of GE HealthCare Technologies during the second quarter valued at approximately $64,000. Boit C F David purchased a new stake in GE HealthCare Technologies in the second quarter worth $102,000. Sanders Morris Harris LLC purchased a new position in GE HealthCare Technologies during the 2nd quarter valued at $201,000. Finally, Flagship Harbor Advisors LLC bought a new position in GE HealthCare Technologies in the 2nd quarter worth $234,000. Institutional investors own 79.18% of the company’s stock.
Analyst Ratings Changes
Several equities analysts recently issued reports on GEHC shares. Argus began coverage on shares of GE HealthCare Technologies in a research note on Friday, August 25th. They issued a “buy” rating and a $80.00 price target for the company. Bank of America began coverage on GE HealthCare Technologies in a report on Monday, July 31st. They issued a “neutral” rating and a $82.00 price objective for the company. Wells Fargo & Company assumed coverage on shares of GE HealthCare Technologies in a report on Wednesday, August 16th. They set an “overweight” rating and a $90.00 target price on the stock. Finally, Morgan Stanley initiated coverage on shares of GE HealthCare Technologies in a research report on Tuesday, June 27th. They set an “equal weight” rating for the company. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $89.25.
Insiders Place Their Bets
In other news, CEO Kevin Michael O’neill sold 15,609 shares of the firm’s stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $77.32, for a total transaction of $1,206,887.88. Following the sale, the chief executive officer now owns 24,025 shares of the company’s stock, valued at approximately $1,857,613. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.21% of the stock is owned by insiders.
GE HealthCare Technologies Stock Performance
GE HealthCare Technologies stock traded up $0.43 during trading hours on Friday, hitting $66.43. The stock had a trading volume of 6,711,139 shares, compared to its average volume of 3,091,351. The stock’s 50-day moving average price is $73.37 and its 200-day moving average price is $77.06. GE HealthCare Technologies Inc. has a 12-month low of $53.00 and a 12-month high of $87.83. The company has a quick ratio of 0.92, a current ratio of 1.22 and a debt-to-equity ratio of 1.44.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its quarterly earnings data on Tuesday, July 25th. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.87 by $0.05. The business had revenue of $4.82 billion during the quarter, compared to the consensus estimate of $4.79 billion. The firm’s revenue was up 7.4% on a year-over-year basis. Equities analysts predict that GE HealthCare Technologies Inc. will post 3.8 EPS for the current year.
GE HealthCare Technologies Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, August 15th. Investors of record on Friday, July 21st were issued a $0.03 dividend. The ex-dividend date was Thursday, July 20th. This represents a $0.12 annualized dividend and a yield of 0.18%.
GE HealthCare Technologies Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally.
- Five stocks we like better than GE HealthCare Technologies
- What Does Downgrade Mean in Investing?
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- When to Sell a Stock for Profit or Loss
- MarketBeat Week in Review – 9/11 – 9/15
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.